FDA’s New ANDA Pilot: A Win for U.S. Manufacturing
FDA’s ANDA Prioritization Pilot: What It Means for U.S. Generics and CDMOs
Read More
Digital Confidence: Building Trust in Sterile Manufacturing
The sterile injectable space is evolving quickly, and capacity and compliance alone are no longer en...
Read More
1 Min. Read
Pharma Tariffs Push for U.S. Production
What the New Pharma Tariff Means for CDMOs and Sterile Injectables The U.S. just announced a propose...
Read More
1 Min. Read
A Business-Minded Guide to Injectable Solutions and Market Trends
You don’t need a PhD in biochemistry to work in the pharmaceutical industry. However, understanding ...
Read More
3 Min. Read
Special Considerations for Developing Parenteral Formulations
Compared to oral and transdermal medicine, parenteral formulations are potent and fast-acting. With ...
Read More
3 Min. Read